Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTRStephen R. Spellman, Mariam Allbee-Johnson, Ke Xu et al.|Transplantation and Cellular Therapy|2025Cited by 80
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic TransplantationAbraham S. Kanate, Mehdi Hamadani, Wael Saber et al.|Transplantation and Cellular Therapy|2017Cited by 11
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377Stephen R. Spellman, Mariam Allbee-Johnson, Ke Xu et al.|Transplantation and Cellular Therapy|2025Cited by 2
Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)Mehdi Hamadani, Abraham S. Kanate, Marcelo C. Pasquini et al.|Transplantation and Cellular Therapy|2016Cited by 1